News
-
Scemblix listed
Tuesday | May 30 2023NOVARTIS Australia's Scemblix (asciminib) is now listed on the PBS for the treatment of adult patients with Philadelphia chromosome-positive chronic myeloid leukaemia in chronic phase (Ph CML-CP), previously treated with two or more tyrosine kinase inhibitors (TKI).
-
Musk’s Neuralink promise ‘misleading’
Tuesday | May 30 2023ELON Musk's brain-chip firm says it has received approval from the US Food and Drugs Administration to conduct its first tests on humans.
-
Mental Health Prize nominations open
Tuesday | May 30 2023NOMINATIONS are now open for the prestigious Australian Mental Health Prize 2023.
-
Dispensary Corner 30 May 23
Tuesday | May 30 2023THE latest retailing financial phenomenon is Buy Now Pay Later (BNPL), but a New Zealand pizza chain is taking things to the extreme by offering customers the opportunity to pay for their pie after they die.
-
PSA elects top leaders
Monday | May 29 2023DR FEI Sim (pictured) has been re-elected as the National President, and Chair of the National Board of the Pharmaceutical Society of Australia (PSA), last week.
-
Palliative care program
Monday | May 29 2023A NEW Pharmaceutical Society of Australia (PSA) training program announced last week could see pharmacists enhance support for patients receiving palliative care.
-
Potential collusion probe
Monday | May 29 2023THE US Federal Trade Commission (FTC) is probing whether Abbott Laboratories and other companies that make baby formula colluded in bidding on state contracts, according to a document posted on the agency's website.
-
AI game changer in fight
Monday | May 29 2023RESEARCHERS have used artificial intelligence (AI) to discover a new antibiotic that can kill a deadly species of superbug.
-
-
Gluten-free bean
Monday | May 29 2023NOVA Pharmaceuticals Glucoboost jelly beans offers pharmacy customers more choice as it is gluten-free.
